Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective, Observational Chart Review Study Evaluating Clinical Effectiveness and Disease/Treatment Management Among Patients Who Initiated Long-term Prophylaxis With Takhzyro® in a Real-world Setting

NCT04861090 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT04861090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04861090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective, Observational Chart Review Study Evaluating Clinical Effectiveness and Disease/Treatment Management Among Patients Who Initiated Long-term Prophylaxis With Takhzyro® in a Real-world Setting
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
September 15, 2021
Completion date
June 30, 2022
Enrollment
207 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary angioedema (hae)